Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Male hormones can decrease the ability of immune cells to fight bacteria.

Analog 23 is a promising compound for prostate cancer treatment.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Certain gene variations are significantly linked to hair loss, especially in white people.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Chromosomal differences affect how muscle cells respond to testosterone.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Mutations in certain receptors can cause diseases and offer new treatment options.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Moxibustion may help improve ovarian function by changing androgen levels.

Androgens may influence bladder cancer progression by affecting cellular behavior.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.